Home
CTOR vs OFAL Comparison

CTOR vs OFAL Comparison

Compare CTOR & OFAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTOR

OFAL

Machine Learning Prediction

ML Decision
CTOR
OFAL

Stock Information

Founded
CTOR 2021
OFAL 2013

Country
CTOR United States
OFAL Hong Kong

Employees
CTOR N/A
OFAL N/A

Industry
CTOR
OFAL Military/Government/Technical

Sector
CTOR
OFAL Consumer Discretionary

Exchange
CTOR NYSE
OFAL Nasdaq

Market Cap
CTOR 52.2M
OFAL 62.1M

IPO Year
CTOR N/A
OFAL 2025

Fundamental

Price
CTOR $0.89
OFAL $5.26

Analyst Decision
CTOR Buy
OFAL

Analyst Count
CTOR 2
OFAL 0

Target Price
CTOR $6.00
OFAL N/A

AVG Volume (30 Days)
CTOR 42.7K
OFAL 2.3M

Earning Date
CTOR 05-14-2025
OFAL 01-01-0001

Dividend Yield
CTOR N/A
OFAL N/A

EPS Growth
CTOR N/A
OFAL N/A

EPS
CTOR N/A
OFAL N/A

Revenue
CTOR N/A
OFAL $386,355.00

Revenue This Year
CTOR N/A
OFAL N/A

Revenue Next Year
CTOR N/A
OFAL N/A

P/E Ratio
CTOR N/A
OFAL N/A

Revenue Growth
CTOR N/A
OFAL N/A

52 Week Low
CTOR $0.55
OFAL $3.75

52 Week High
CTOR $49.00
OFAL $9.79

Technical

Relative Strength Index (RSI)
CTOR N/A
OFAL N/A

Support Level
CTOR N/A
OFAL N/A

Resistance Level
CTOR N/A
OFAL N/A

Average True Range (ATR)
CTOR 0.00
OFAL 0.00

MACD
CTOR 0.00
OFAL 0.00

Stochastic Oscillator
CTOR 0.00
OFAL 0.00

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Share on Social Networks: